Cargando…
Effect of the relationship between anaemia and systemic inflammation on the risk of incident tuberculosis and death in people with advanced HIV: a sub-analysis of the REMEMBER trial
BACKGROUND: Tuberculosis (TB) is an infectious morbidity that commonly occurs in people living with HIV (PWH) and increases the progression of HIV disease, as well as the risk of death. Simple markers of progression are much needed to identify those at highest risk for poor outcome. This study aimed...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242630/ https://www.ncbi.nlm.nih.gov/pubmed/37287871 http://dx.doi.org/10.1016/j.eclinm.2023.102030 |
_version_ | 1785054258808225792 |
---|---|
author | Araújo-Pereira, Mariana Krishnan, Sonya Salgame, Padmini Manabe, Yukari C. Hosseinipour, Mina C. Bisson, Gregory Severe, Damocles Patrice Rouzier, Vanessa Leong, Samantha Mave, Vidya Sawe, Fredrick Kipyego Siika, Abraham M. Kanyama, Cecilia Dadabhai, Sufia S. Lama, Javier R. Valencia-Huamani, Javier Badal-Faesen, Sharlaa Lalloo, Umesh Gangaram Naidoo, Kogieleum Mohapi, Lerato Kityo, Cissy Andrade, Bruno B. Gupta, Amita |
author_facet | Araújo-Pereira, Mariana Krishnan, Sonya Salgame, Padmini Manabe, Yukari C. Hosseinipour, Mina C. Bisson, Gregory Severe, Damocles Patrice Rouzier, Vanessa Leong, Samantha Mave, Vidya Sawe, Fredrick Kipyego Siika, Abraham M. Kanyama, Cecilia Dadabhai, Sufia S. Lama, Javier R. Valencia-Huamani, Javier Badal-Faesen, Sharlaa Lalloo, Umesh Gangaram Naidoo, Kogieleum Mohapi, Lerato Kityo, Cissy Andrade, Bruno B. Gupta, Amita |
author_sort | Araújo-Pereira, Mariana |
collection | PubMed |
description | BACKGROUND: Tuberculosis (TB) is an infectious morbidity that commonly occurs in people living with HIV (PWH) and increases the progression of HIV disease, as well as the risk of death. Simple markers of progression are much needed to identify those at highest risk for poor outcome. This study aimed to assess how baseline severity of anaemia and associated inflammatory profiles impact death and the incidence of TB in a cohort of PWH who received TB preventive therapy (TPT). METHODS: This study is a secondary posthoc analysis of the AIDS Clinical Trials Group A5274 REMEMBER clinical trial (NCT0138008), an open-label randomised clinical trial of antiretroviral-naïve PWH with CD4 <50 cells/μL, performed from October 31, 2011 to June 9, 2014, from 18 outpatient research clinics in 10 low- and middle-income countries (Malawi, South Africa, Haiti, Kenya, Zambia, India, Brazil, Zimbabwe, Peru, and Uganda) who initiated antiretroviral therapy and either isoniazid TPT or 4-drug empiric TB therapy. Plasma concentrations of several soluble inflammatory biomarkers were measured prior to the commencement of antiretroviral and anti-TB therapies, and participants were followed up for at least 48 weeks. Incident TB or death during this period were primary outcomes. We performed multidimensional analyses, logistic regression analyses, survival curves, and Bayesian network analyses to delineate associations between anaemia, laboratory parameters, and clinical outcomes. FINDINGS: Of all 269 participants, 76.2% (n = 205) were anaemic, and 31.2% (n = 84) had severe anaemia. PWH with moderate/severe anaemia exhibited a pronounced systemic pro-inflammatory profile compared to those with mild or without anaemia, hallmarked by a substantial increase in IL-6 plasma concentrations. Moderate/severe anaemia was also associated with incident TB incidence (aOR: 3.59, 95% CI: 1.32–9.76, p = 0.012) and death (aOR: 3.63, 95% CI: 1.07–12.33, p = 0.039). INTERPRETATION: Our findings suggest that PWH with moderate/severe anaemia display a distinct pro-inflammatory profile. The presence of moderate/severe anaemia pre-ART was independently associated with the development of TB and death. PWH with anaemia should be monitored closely to minimise the occurrence of unfavourable outcomes. FUNDING: 10.13039/100000002National Institutes of Health. |
format | Online Article Text |
id | pubmed-10242630 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-102426302023-06-07 Effect of the relationship between anaemia and systemic inflammation on the risk of incident tuberculosis and death in people with advanced HIV: a sub-analysis of the REMEMBER trial Araújo-Pereira, Mariana Krishnan, Sonya Salgame, Padmini Manabe, Yukari C. Hosseinipour, Mina C. Bisson, Gregory Severe, Damocles Patrice Rouzier, Vanessa Leong, Samantha Mave, Vidya Sawe, Fredrick Kipyego Siika, Abraham M. Kanyama, Cecilia Dadabhai, Sufia S. Lama, Javier R. Valencia-Huamani, Javier Badal-Faesen, Sharlaa Lalloo, Umesh Gangaram Naidoo, Kogieleum Mohapi, Lerato Kityo, Cissy Andrade, Bruno B. Gupta, Amita eClinicalMedicine Articles BACKGROUND: Tuberculosis (TB) is an infectious morbidity that commonly occurs in people living with HIV (PWH) and increases the progression of HIV disease, as well as the risk of death. Simple markers of progression are much needed to identify those at highest risk for poor outcome. This study aimed to assess how baseline severity of anaemia and associated inflammatory profiles impact death and the incidence of TB in a cohort of PWH who received TB preventive therapy (TPT). METHODS: This study is a secondary posthoc analysis of the AIDS Clinical Trials Group A5274 REMEMBER clinical trial (NCT0138008), an open-label randomised clinical trial of antiretroviral-naïve PWH with CD4 <50 cells/μL, performed from October 31, 2011 to June 9, 2014, from 18 outpatient research clinics in 10 low- and middle-income countries (Malawi, South Africa, Haiti, Kenya, Zambia, India, Brazil, Zimbabwe, Peru, and Uganda) who initiated antiretroviral therapy and either isoniazid TPT or 4-drug empiric TB therapy. Plasma concentrations of several soluble inflammatory biomarkers were measured prior to the commencement of antiretroviral and anti-TB therapies, and participants were followed up for at least 48 weeks. Incident TB or death during this period were primary outcomes. We performed multidimensional analyses, logistic regression analyses, survival curves, and Bayesian network analyses to delineate associations between anaemia, laboratory parameters, and clinical outcomes. FINDINGS: Of all 269 participants, 76.2% (n = 205) were anaemic, and 31.2% (n = 84) had severe anaemia. PWH with moderate/severe anaemia exhibited a pronounced systemic pro-inflammatory profile compared to those with mild or without anaemia, hallmarked by a substantial increase in IL-6 plasma concentrations. Moderate/severe anaemia was also associated with incident TB incidence (aOR: 3.59, 95% CI: 1.32–9.76, p = 0.012) and death (aOR: 3.63, 95% CI: 1.07–12.33, p = 0.039). INTERPRETATION: Our findings suggest that PWH with moderate/severe anaemia display a distinct pro-inflammatory profile. The presence of moderate/severe anaemia pre-ART was independently associated with the development of TB and death. PWH with anaemia should be monitored closely to minimise the occurrence of unfavourable outcomes. FUNDING: 10.13039/100000002National Institutes of Health. Elsevier 2023-06-02 /pmc/articles/PMC10242630/ /pubmed/37287871 http://dx.doi.org/10.1016/j.eclinm.2023.102030 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Articles Araújo-Pereira, Mariana Krishnan, Sonya Salgame, Padmini Manabe, Yukari C. Hosseinipour, Mina C. Bisson, Gregory Severe, Damocles Patrice Rouzier, Vanessa Leong, Samantha Mave, Vidya Sawe, Fredrick Kipyego Siika, Abraham M. Kanyama, Cecilia Dadabhai, Sufia S. Lama, Javier R. Valencia-Huamani, Javier Badal-Faesen, Sharlaa Lalloo, Umesh Gangaram Naidoo, Kogieleum Mohapi, Lerato Kityo, Cissy Andrade, Bruno B. Gupta, Amita Effect of the relationship between anaemia and systemic inflammation on the risk of incident tuberculosis and death in people with advanced HIV: a sub-analysis of the REMEMBER trial |
title | Effect of the relationship between anaemia and systemic inflammation on the risk of incident tuberculosis and death in people with advanced HIV: a sub-analysis of the REMEMBER trial |
title_full | Effect of the relationship between anaemia and systemic inflammation on the risk of incident tuberculosis and death in people with advanced HIV: a sub-analysis of the REMEMBER trial |
title_fullStr | Effect of the relationship between anaemia and systemic inflammation on the risk of incident tuberculosis and death in people with advanced HIV: a sub-analysis of the REMEMBER trial |
title_full_unstemmed | Effect of the relationship between anaemia and systemic inflammation on the risk of incident tuberculosis and death in people with advanced HIV: a sub-analysis of the REMEMBER trial |
title_short | Effect of the relationship between anaemia and systemic inflammation on the risk of incident tuberculosis and death in people with advanced HIV: a sub-analysis of the REMEMBER trial |
title_sort | effect of the relationship between anaemia and systemic inflammation on the risk of incident tuberculosis and death in people with advanced hiv: a sub-analysis of the remember trial |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242630/ https://www.ncbi.nlm.nih.gov/pubmed/37287871 http://dx.doi.org/10.1016/j.eclinm.2023.102030 |
work_keys_str_mv | AT araujopereiramariana effectoftherelationshipbetweenanaemiaandsystemicinflammationontheriskofincidenttuberculosisanddeathinpeoplewithadvancedhivasubanalysisoftheremembertrial AT krishnansonya effectoftherelationshipbetweenanaemiaandsystemicinflammationontheriskofincidenttuberculosisanddeathinpeoplewithadvancedhivasubanalysisoftheremembertrial AT salgamepadmini effectoftherelationshipbetweenanaemiaandsystemicinflammationontheriskofincidenttuberculosisanddeathinpeoplewithadvancedhivasubanalysisoftheremembertrial AT manabeyukaric effectoftherelationshipbetweenanaemiaandsystemicinflammationontheriskofincidenttuberculosisanddeathinpeoplewithadvancedhivasubanalysisoftheremembertrial AT hosseinipourminac effectoftherelationshipbetweenanaemiaandsystemicinflammationontheriskofincidenttuberculosisanddeathinpeoplewithadvancedhivasubanalysisoftheremembertrial AT bissongregory effectoftherelationshipbetweenanaemiaandsystemicinflammationontheriskofincidenttuberculosisanddeathinpeoplewithadvancedhivasubanalysisoftheremembertrial AT severedamoclespatrice effectoftherelationshipbetweenanaemiaandsystemicinflammationontheriskofincidenttuberculosisanddeathinpeoplewithadvancedhivasubanalysisoftheremembertrial AT rouziervanessa effectoftherelationshipbetweenanaemiaandsystemicinflammationontheriskofincidenttuberculosisanddeathinpeoplewithadvancedhivasubanalysisoftheremembertrial AT leongsamantha effectoftherelationshipbetweenanaemiaandsystemicinflammationontheriskofincidenttuberculosisanddeathinpeoplewithadvancedhivasubanalysisoftheremembertrial AT mavevidya effectoftherelationshipbetweenanaemiaandsystemicinflammationontheriskofincidenttuberculosisanddeathinpeoplewithadvancedhivasubanalysisoftheremembertrial AT sawefredrickkipyego effectoftherelationshipbetweenanaemiaandsystemicinflammationontheriskofincidenttuberculosisanddeathinpeoplewithadvancedhivasubanalysisoftheremembertrial AT siikaabrahamm effectoftherelationshipbetweenanaemiaandsystemicinflammationontheriskofincidenttuberculosisanddeathinpeoplewithadvancedhivasubanalysisoftheremembertrial AT kanyamacecilia effectoftherelationshipbetweenanaemiaandsystemicinflammationontheriskofincidenttuberculosisanddeathinpeoplewithadvancedhivasubanalysisoftheremembertrial AT dadabhaisufias effectoftherelationshipbetweenanaemiaandsystemicinflammationontheriskofincidenttuberculosisanddeathinpeoplewithadvancedhivasubanalysisoftheremembertrial AT lamajavierr effectoftherelationshipbetweenanaemiaandsystemicinflammationontheriskofincidenttuberculosisanddeathinpeoplewithadvancedhivasubanalysisoftheremembertrial AT valenciahuamanijavier effectoftherelationshipbetweenanaemiaandsystemicinflammationontheriskofincidenttuberculosisanddeathinpeoplewithadvancedhivasubanalysisoftheremembertrial AT badalfaesensharlaa effectoftherelationshipbetweenanaemiaandsystemicinflammationontheriskofincidenttuberculosisanddeathinpeoplewithadvancedhivasubanalysisoftheremembertrial AT lallooumeshgangaram effectoftherelationshipbetweenanaemiaandsystemicinflammationontheriskofincidenttuberculosisanddeathinpeoplewithadvancedhivasubanalysisoftheremembertrial AT naidookogieleum effectoftherelationshipbetweenanaemiaandsystemicinflammationontheriskofincidenttuberculosisanddeathinpeoplewithadvancedhivasubanalysisoftheremembertrial AT mohapilerato effectoftherelationshipbetweenanaemiaandsystemicinflammationontheriskofincidenttuberculosisanddeathinpeoplewithadvancedhivasubanalysisoftheremembertrial AT kityocissy effectoftherelationshipbetweenanaemiaandsystemicinflammationontheriskofincidenttuberculosisanddeathinpeoplewithadvancedhivasubanalysisoftheremembertrial AT andradebrunob effectoftherelationshipbetweenanaemiaandsystemicinflammationontheriskofincidenttuberculosisanddeathinpeoplewithadvancedhivasubanalysisoftheremembertrial AT guptaamita effectoftherelationshipbetweenanaemiaandsystemicinflammationontheriskofincidenttuberculosisanddeathinpeoplewithadvancedhivasubanalysisoftheremembertrial |